ERBB2 and neoplasm: Both HER-2 (4.5%; p < 0.005) and MUC-1 (19%; p < 0.05) tetramers detected the TCRs on CD8 + T-cells that were primed with the tumour-specific lysate and full cocktail-matured DCs (Fig. 4).